General notes

Published on 01/04/2015 by admin

Filed under Radiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1609 times

Chapter 1 General notes

Radiology

The procedures are laid out under a number of sub-headings, which follow a standard sequence. The general order is outlined below, together with certain points that have been omitted from the discussion of each procedure in order to avoid repetition. Minor deviations from this sequence will be found in the text where this is felt to be more appropriate.

Contraindications

All radiological procedures carry a risk. The risk incurred by undertaking the procedure must be balanced against the benefit to the patient as deduced from the information obtained. Contraindications may be relative (the majority) or absolute. Factors that increase the risk to the patient can be categorized under three headings: due to radiation; due to the contrast medium; due to the technique.

Risk due to radiation

Radiation effects on humans may be:

2. somatic injuries, which fall into two groups: stochastic and deterministic. The latter, e.g. skin erythema and cataracts, occur when a critical threshold has been reached and are rarely relevant to diagnostic radiology. Stochastic effects, such as malignancy, are ‘all or none’. The cancer produced by a small dose is the same as the cancer produced by a large dose, but the frequency of its appearance is less with the smaller dose. The current consensus held by national and international radiological protection organizations is that, for comparatively low doses, the risk of both radiation-induced cancer and hereditary disease is assumed to increase linearly with increasing radiation dose, with no threshold (the so-called linear no threshold model).1 It is impossible to totally avoid staff and patient exposure to radiation. The adverse effects of radiation, therefore, cannot be completely eliminated, but must be minimized. There is an excess of cancers following diagnostic levels of irradiation to the fetus2 and the female breast,3 and trends of increased rates of cancer are seen in workers in the nuclear power industry exposed to low doses.4 In the United Kingdom about 0.6% of the overall cumulative risk of cancer by the age of 75 years could be attributable to diagnostic X-rays. This percentage is equivalent to about 700 new cases of cancer per year.5

There are legal regulations which guide the use of diagnostic radiation (see Appendix I). These are the basic principles:

Justification is particularly important when considering the irradiation of women of reproductive age, because of the risks to the developing fetus. The mammalian embryo and fetus are highly radiosensitive. The potential effects of in-utero radiation exposure on a developing fetus include prenatal death, intrauterine growth restriction, small head size, mental retardation, organ malformation and childhood cancer. The risk of each effect depends on the gestational age at the time of the exposure and the absorbed radiation dose.2 Most diagnostic radiation procedures will lead to a fetal absorbed dose of less than 1 mGy for imaging beyond the maternal abdomen/pelvis and less than 10 mGy for direct abdominal/pelvic or nuclear medicine imaging.7 There are important exceptions which result in higher doses. Computed tomography (CT) scanning of the maternal pelvis may result in fetal doses below the level thought to induce neurologic detriment to the fetus, but, theoretically, may double the fetal risk for developing a childhood cancer.8

Almost always, if a diagnostic radiology examination is medically indicated, the risk to the mother of not doing the procedure is greater than the risk of potential harm to the fetus.9 However, whenever possible, alternative investigation techniques not involving ionizing radiation should be considered before a decision is taken to use ionizing radiation in a female of reproductive age. It is extremely important to have a robust process in place that prevents inappropriate or unnecessary ionizing radiation exposure to the fetus. Previous guidelines recommended that all non-emergency examinations that would involve irradiation of the lower abdomen or pelvis in women of child-bearing age be restricted to the first 10 days (10-day rule) or 28 days (28-day rule) following the onset of a menstrual period.10 This led to some potential practical difficulties, e.g. for women who denied recent sexual intercourse, for those with an irregular menstrual cycle or for those who had been taking the oral contraceptive pill. There are also concerns:

Joint guidance from the National Radiological Protection Board, the College of Radiographers and the Royal College of Radiologists recommends the following:11

When a female of reproductive age presents for an examination in which the primary beam irradiates the pelvic area, or for a procedure involving radioactive isotopes, she should be asked whether she is or might be pregnant. If the patient cannot exclude the possibility of pregnancy, she should be asked if her menstrual period is overdue. Her answer should be recorded and, depending on the answer, the patient assigned to one of the following four groups:

If the examination is necessary, a technique that minimizes the number of views and the absorbed dose per examination should be utilized. However, the quality of the examination should not be reduced to the level where its diagnostic value is impaired. The risk to the patient of an incorrect diagnosis may be greater than the risk of irradiating the fetus. Radiography of areas that are remote from the pelvis and abdomen may be safely performed at any time during pregnancy with good collimation and lead protection.

Patient preparation

3. Except in emergencies, in circumstances when consent cannot be obtained, patient consent to treatment is a legal requirement for medical care.12 Consent should be obtained in a suitable environment and only after appropriate and relevant information has been given to the patient.13 Patient consent may be:

The radiologist must assess a child’s capacity to decide whether to give consent for or refuse an investigation. At age 16 years a young person can be treated as an adult and can be presumed to have the capacity to understand the nature, purpose and possible consequences of the proposed investigation, as well as the consequences of non-investigation. Following case law in the United Kingdom (Gillick v West Norfolk and Wisbech Area Health Authority) and the introduction of The Children Act 1989, in which the capacity of children to consent has been linked with the concept of individual ability to understand the implications of medical treatment, there has come into existence a standard known as ‘Gillick competence’. Under the age of 16 years children may have the capacity to consent depending on their maturity and ability to understand what is involved. When a competent child refuses treatment, a person with parental responsibility or the court may authorize investigations or treatment which is in the child’s best interests. In Scotland the situation is different: parents cannot authorize procedures a competent child has refused. Legal advice may be helpful in dealing with these cases.14

References

1 Wall B.F., Kendall G.M., Edwards A.A., et al. What are the risks from medical X-rays and other low dose radiation? Br. J. Radiol.. 2006;79(940):285-294.

2 McCollough C.H., Scheuler B.A., Atwell T.D., et al. Radiation exposure and pregnancy: when should we be concerned? Radiographics. 2007;27(4):909-917.

3 Einstein A.J., Henzlova M.J., Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 2007;298(3):317-323.

4 Cardis E., Vrijheid M., Blettner M., et al. The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat. Res.. 2007;167(4):396-416.

5 Berrington de González A., Darby S. Risk of cancer from diagnostic X-rays: estimates from the UK and 14 other countries. Lancet. 2004;363(9406):345-351.

6 International Commission on Radiological Protection. The optimization of radiological protection: broadening the process. ICRP publication 101. Ann. ICRP. 36(3), 2006.

7 Lowe S.A. Diagnostic radiography in pregnancy: risks and reality. Aust. N. Z. J. Obstet. Gynaecol.. 2004;44(3):191-196.

8 Hurwitz L.M., Yoshizumi T., Reiman R.E., et al. Radiation dose to the fetus from body MDCT during early gestation. Am. J. Roentgenol.. 2006;186(3):871-876.

9 International Commission on Radiological Protection. Pregnancy and medical radiation. Ann. ICRP. 2000;30(1):1-43.

10 Bury B., Hufton A., Adams J. Editorial. Radiation and women of childbearing potential. BMJ. 1995;310:1022-1023.

.

11 Sharp C., Shrimpton J.A., Bury R.F. Diagnostic Medical Exposures: Advice on Exposure to Ionising Radiation during Pregnancy. London: National Radiological Protection Board, 1998.

12 The Royal College of Radiologists. Standards for Patient Consent Particular to Radiology. London: The Royal College of Radiologists, 2005.

13 General Medical Council. Consent: Patients and Doctors Making Decisions Together. London: General Medical Council, 2008.

14 General Medical Council. 0–18 years: Guidance for all Doctors. London: General Medical Council, 2007.

Radionuclide Imaging

RADIOPHARMACEUTICALS

Radionuclides are shown in symbolic notation, the most frequently used in nuclear medicine being 99mTc, a 140-keV gamma-emitting radioisotope of the element technetium with T1/2 = 6.0 hours.

Activity administered

The maximum activity values quoted in the text are those currently recommended as diagnostic reference levels in the ARSAC Guidance Notes.2 The unit used is the SI unit, the megabecquerel (MBq). Millicuries (mCi) are still used in some countries, notably the US; 1 mCi = 37 MBq.

Radiation doses are quoted as the adult effective dose (ED) in millisieverts (mSv) from the ARSAC Guidance Notes.

The regulations require that doses to patients are kept as low as reasonably practicable (the ALARP principle) and that exposure follows accepted practice. Centres will frequently be able to administer activities below the maximum, depending upon the capabilities of their equipment and local protocols. Typical figures are given in the text where they differ from the diagnostic reference levels. In certain circumstances, the person clinically directing (ARSAC licence holder) may use activity higher than the recommended maximum for a named patient, for example for an obese patient where attenuation would otherwise degrade image quality.

ARSAC recommends that activities administered for paediatric investigations should be reduced according to body weight, but no longer in a linear relationship. The guidance notes include a table of suggested scaling factors based on producing comparable quality images to those expected for adults, with a minimum activity of 10% of the adult value for most purposes. However, organs develop at different rates (e.g. the brain achieves 95% of its adult size by age 5 years) and some radiopharmaceuticals behave differently in children, so the administered activity may need to be adjusted accordingly. It should be noted that when scaling activity according to the suggested factors, the radiation dose for a child may be higher than that for an adult.

Technique

Aftercare

Radiation safety

Special instructions should be given to patients who are breast feeding regarding expression of milk and interruption of feeding.2 Precautions may have to be taken with patients leaving hospital or returning to wards, depending upon the radionuclide and activity administered. These precautions were reviewed following the introduction of the Ionising Radiation Regulations 1999 and the adoption of lower dose limits to members of the public, and appropriate guidance has been published.4

Computed Tomography

Oral contrast medium

For examinations of the abdomen, opacifying the bowel satisfactorily can be problematic. Water-soluble contrast medium (e.g. 20 ml Urografin 150 diluted in 1 l of orange squash to disguise the taste, preflavoured contrast such as 20 ml Gastromiro diluted in 1 l of water) or low-density barium suspensions (2% w/v) can be used. Timing of administration is given in Table 1.1. Doses of contrast media in children depend upon age.

Table 1.1 Timing and volume for oral contrast medium in CT

  Volume (ml) Time before scan (min)
Adult
Full abdomen and pelvis 1000 Gradually over 1 h before scanning
Upper abdomen, e.g. pancreas 500 Gradually over 0.5 h before scanning
Child
Newborn 60–90 image
1 month–1 year 120–240
1–5 years 240–360
5–10 years 360–480
Over 10 years As for adult
If the large bowel needs to be opacified then give the contrast medium the night before or 3–4 h before scanning

MAGNETIC RESONANCE IMAGING

SAFETY IN MAGNETIC RESONANCE IMAGING

MRI has generally been a very safe process because of the care taken by equipment manufacturers and MRI staff. However, there are significant potential hazards1 to patients and staff due to:

Effects due to magnetic fields

Static field

The strength of the static magnetic field used in MRI is measured in units of gauss or tesla (10000 gauss = 1 tesla (T)). The earth’s magnetic field is approximately 0.6 gauss. Current guidelines on MRI field strength are given in Table 1.2.

Table 1.2 Guidelines on whole-body exposure to static magnetic fields4

Level Magnetic field (T)
Normal operating mode <2
First level operating mode (one or more outputs reach a value that may cause physiological stress and which requires medical supervision) 2–4
Second level operating mode (one or more outputs reach a value that may produce significant risk for patients, for which explicit ethical approval is required) >4

Biological effects

Despite extensive research, no significant deleterious physiological effects have been proven. There have been reports of minor changes, such as alteration in electrocardiogram (T-wave elevation)2 presumed to be due to electrodynamic forces on moving ions in blood vessels which might result in a reduction of blood-flow velocity. This change is purely temporary and disappears on removal from the field. Studies of volunteers exposed to 8 T static magnetic fields have shown no clinically significant effect on heart rate, respiratory rate, systolic and diastolic blood pressure, finger pulse oxygenation levels and core body temperature.3 However, it was noted that movement within the 8 T field could cause vertigo. Teratogenesis in humans is thought unlikely at the field strengths used in clinical MRI.

Gradient field

Biological effects

The rapidly switched magnetic gradients used in MRI can induce electric fields in a patient which may result in nerve or muscle stimulation, including cardiac muscle stimulation. The strength of these is dependent on the rate of change of the field and the size of the subject.5 Studies have shown that the threshold for peripheral nerve stimulation is lower than that for cardiac or brain stimulation.6 Although possible cardiac fibrillation or brain stimulation are major safety issues, peripheral nerve stimulation is a practical concern because, if sufficiently intense, it can be intolerable and result in termination of the examination. Recommendations for safety limits on gradient fields state that the system must not have a gradient output that exceeds the limit for peripheral nerve stimulation.5 This will protect against cardiac fibrillation.

Recommendations for safety

Detailed MRI safety recommendations have been published by the American College of Radiology.7 It is essential that all MRI units have clear MRI safety policies and protocols, including a detailed screening questionnaire for all patients and staff (Table 1.3).

Table 1.3 Questions which should be included in a screening questionnaire for magnetic resonance imaging patients and staff

Question to patient or staff member Action
Do you have a pacemaker or have you had a heart operation? Pacemaker – if present patient must not enter controlled area.
  Heart operation – establish if any metal valve prosthesis, intravascular device or recent metallic surgical clip insertion and check MR compatibility.
Could you possibly be pregnant? See text.
Have you ever had any penetrating injury, especially to the eyes, even if it was years ago? Establish details. If necessary arrange X-ray of orbits or relevant area to determine if there is any metallic foreign body.
Have you ever had any operations to your head, chest or neck? Find out details. If any metallic aneurysm or haemostatic clips or metallic prosthesis/implant then check MR compatibility.
Do you have any joint replacements or any other body implants? Check details of surgery and MR compatibility of joint replacement or implant.
Have you removed all metal objects and credit cards from your clothing and possessions? This must be done before entering the controlled area.

ULTRASONOGRAPHY

Patient preparation

For many US examinations no preparation is required. This includes examination of tissues such as thyroid, breast, testes, musculoskeletal, vascular and cardiac. In certain situations simple preparatory measures are required.